Therapeutic Outcomes of (177)Lu-PSMA Targeted Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Single-Center Study

OBJECTIVE(S): This study aimed to evaluate the therapeutic outcomes of (177)Lutetium ((177)Lu)-PSMA-617 in metastatic castrate-resistant prostate cancer (mCRPC) patients, based on post-treatment imaging findings. METHODS: All post-therapeutic scans were collected retrospectively from patients treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirshahvalad, Seyed Ali, Farzanefar, Saeed, Abbasi, Mehrshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803619/
https://www.ncbi.nlm.nih.gov/pubmed/36619180
http://dx.doi.org/10.22038/AOJNMB.2022.64964.1454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803619/
https://www.ncbi.nlm.nih.gov/pubmed/36619180
http://dx.doi.org/10.22038/AOJNMB.2022.64964.1454

Ejemplares similares